Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Unknown Risk Should be Considered High-Risk in Myelodysplastic Neoplasms: A Multicenter Study in 219 Patients in Colombia

Angela Esparza-Albornoz, Andres Prieto-Torres, Diego Lopera, Oscar Reyes-Cortes, Humberto Martinez-Cordero

Blood (2024) 144 (Supplement 1): 6753.

https://doi.org/10.1182/blood-2024-211701

Published: 2024

Journal Articles

Using Polatuzumab Plus Chemotherapy for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Real-World Study from the Grupo De Estudio De Linfoproliferativos De Latinoamerica (GELL)

Blood (2024) 144 (Supplement 1): 1718.

https://doi.org/10.1182/blood-2024-211584

Published: 2024

Journal Articles

Low/Intermediate Doses of Melphalan in the Treatment of Triple-Exposed/Refractory Multiple Myeloma: A Case Series from a Reference Center for the Treatment of Multiple Myeloma in Colombia

Humberto Martinez-Cordero, Juan-Carlos Mantilla, Jaime Valdes-Cespedes, Juan Ospina, Maria Spirko, Sebastian Alcala, Mayra Prada-Serrano, Fabian Leon-Chavez, Mario Pereira-Garzon

Blood (2024) 144 (Supplement 1): 7872.

https://doi.org/10.1182/blood-2024-206826

Published: 2024

Journal Articles

Primary CNS Lymphoma in Latin America: A Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL) Survey in 80 Cancer Centers in Latin America

Blood (2023) 142 (Supplement 1): 2422.

https://doi.org/10.1182/blood-2023-190477

Published: 2023

Journal Articles

Clinical Features and Prognostic Factors in Multiple Myeloma Patients from Colombia. Real-World Data from Renehoc Registry

Blood (2023) 142 (Supplement 1): 6636.

https://doi.org/10.1182/blood-2023-181336

Published: 2023

Journal Articles

Renal Failure in Patients with Newly Diagnosed Multiple Myeloma Eligible for Autologous Stem Cell Transplant in LATAM - on Behalf of Gelamm

Humberto Martinez-Cordero, Maria Cynthia Fuentes Lacouture, Seisha Alana Von Glasenapp, Camila Peña, Eloisa Riva

Blood (2023) 142 (Supplement 1): 3346.

https://doi.org/10.1182/blood-2023-190668

Published: 2023

Journal Articles

Freedo mm : A Multicenter Observational Study of Multiple Myeloma in Second Relapse in Colombia

Guillermo Quintero, Sandra Aruachan, Jair Figueroa Emiliani, Kenny Galvez, Luis Antonio Salazar, Melissa Diaz, Diana Camila Buitrago, Humberto Martinez-Cordero, Juliana Saavedra

Blood (2023) 142 (Supplement 1): 6654.

https://doi.org/10.1182/blood-2023-190068

Published: 2023

Journal Articles

Complete Response As a Determinant of Survival in Plasmablastic Lymphoma Plasmablat- GELL001 Study

Humberto Martinez-Cordero, Maria Cynthia Fuentes Lacouture, Paola Spirko, Juan Alejandro Ospina-Idárraga, Jaime Valdes Cespedes, Karen Pellon, Laura Korin, Perla R. Colunga-Pedraza, Henry Idrobo, Andrea Noboa, Luis Mario Villela, Arianna Robles, Alana Von Glasenapp, Perla N Britos, Yusaima Rodriguez, Rosa Oliday Rios Jiménez, Camila Peña, Luis Felipe Rubalcava, Jorge J. Castillo

Blood (2023) 142 (Supplement 1): 6326.

https://doi.org/10.1182/blood-2023-190960

Published: 2023

Journal Articles

Multiple Myeloma Patients Aged 40 Years and Younger Have the Same Prognosis As Older Patients in an Analysis of Real-World Evidence from Latin America: A Study of 1,316 Patients from the Gelamm Latin American Multiple Myeloma Studygroup

Humberto Martinez-Cordero, Camila Peña, Natalia Paola Schutz, Virginia Bove, Fiorella Villano, Rocío Osorio, Mauricio Chandia, Cecilia Beltrán, Javier Schulz, Daniela Cardemil, Carolina Contreras, Carmen Gloria Vergara, Javiera Donoso, Marcela Espinoza, Gabriel La Rocca, Hernán López-Vidal, Pilar León, Macarena Roa, Christine Rojas, Pablo Soto, Sandra Aranda, Vivianne Torres, Paola Ochoa, Patricio Duarte, Guillermina Remaggi, Sebastian Yantorno, Ariel Corzo, Soledad Zabaljauregui, Claudia Shanley, Sergio Lopresti, Sergio Orlando, Veronica Verri, Luis Darío Quiroga, Juan Jose Garcia, Vanesa Fernandez, Dorotea Fantl, Jhoanna Ramirez, Alicia Molina, Pilar Papilco, Alex Mite, Ines Reyes, Brenner Sabando Vélez, Francisca M. Ramirez Aspiazu, Claudia Lucia Sossa, Virginia Abello, Henry Idrobo, Domingo Saavedra, Guillermo Quintero, Lina Gaviria, Rigoberto Gomez, Monica Osuna Pérez, Alicia Henao-Uribe, Luz del Carmen Tarín Arzaga, Omar Cantú-Martínez, David Gomez-Almaguer, Yarely Itzayana García-Navarrete, Antonio Cruz-Mora, Yahveth Cantero-Fortiz, Guillermo J. Ruiz-Arguelles, Eloisa Riva, Isabella Novoa-Caicedo

Blood (2022) 140 (Supplement 1): 7189–7191.

https://doi.org/10.1182/blood-2022-158104

Published: 2022

Journal Articles

Treatment Patterns and Survival of Patients with Relapsed and Refractory Classical Hodgkin Lymphoma in Latin America

Seisha Alana Von Glasenapp Gossen, Humberto Martinez-Cordero, Luis Villela, Perla Rocio Colunga-Pedraza, Fernando Perez-Jacobo, Arianna Robles, Diego Fernando Garces PAZ, Henry Idrobo, Denisse Castro, Sally Rose Paredes, Brady E Beltran, Ana Carolina Oliver, Victoria Irigoin, Juan Alejandro Ospina, Rosa Oliday Rios

Blood (2022) 140 (Supplement 1): 9429–9430.

https://doi.org/10.1182/blood-2022-171102

Published: 2022

Journal Articles

Outcomes after First Rescue Treatment in Patients with Relapsed or Refractory Multiple Myeloma in Colombia

Blood (2021) 138 (Supplement 1): 4745.

https://doi.org/10.1182/blood-2021-154190

Published: 2021

Journal Articles

Clinico-Epidemiological Features of Elderly Patients with Peripheral T-Cell Lymphoma Not Otherwise Specified: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Henry Idrobo, Denisse Castro, Lorena Fiad, Yesenia M. Huerta- Collado, Victoria Otero, Sally Rose Paredes, Juan Esteban Garcia-Robledo, Juan Felipe Lasso, Humberto Martinez-Cordero, Ana Maria Osorio-Gomez, Julian Andres Sanchez-Perea, Bryan Valcarcel, Luis Villela, Marialejandra Alejandra Torres Viera, Brady E Beltran, Jorge J. Castillo, Luis Malpica-Castillo

Blood (2021) 138 (Supplement 1): 2468.

https://doi.org/10.1182/blood-2021-153849

Published: 2021

Journal Articles

A Novel Prognostic Index for Patients with EBV-DLBCL NOS: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2021) 138 (Supplement 1): 1436.

https://doi.org/10.1182/blood-2021-151389

Published: 2021

Journal Articles

Clinicopathological Features and Outcomes of EBV Positive and Negative DLBCL: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2021) 138 (Supplement 1): 1442.

https://doi.org/10.1182/blood-2021-152340

Published: 2021

Journal Articles

Biological and Classical Prognostic Factors with Impact on Overall Survival in Patients with Early Stage (I/II) Diffuse Large B-Cell Lymphoma: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2021) 138 (Supplement 1): 2516.

https://doi.org/10.1182/blood-2021-152724

Published: 2021

Journal Articles

Multiple Myeloma Mortality Incidence Prevalence of Disease - Mmy Mind Study

Humberto Martínez Cordero, MD, Jessica Zapata Malagon, Lorena Cubillos Osorio, Alejandro Rico Mendoza, Alexandra Porras Ramírez, Juan Ospina Idarraga, Henry Idrobo, MD, Viviana Olaya, Kenny Galvez, MD, Sergio Cancelado, MD, Juan Manuel Herrera, MD, Leonardo Bautista Toloza, MD

Blood (2020) 136 (Supplement 1): 10–11.

https://doi.org/10.1182/blood-2020-142376

Published: 2020

Journal Articles

Plasmablastic Lymphoma : 12 Year Experience from a Single Center in Colombia -South America

Paola Spirko, MD, Leonardo José Enciso Olivera, MD, Diana Otero, Bonell Patiño, MD, Cristina Acon-Solano, MD, Sebastian Alcala, MD, Jaime Valdes, Andres Garces, Humberto Martínez Cordero, MD, Jorge J. Castillo, MD

Blood (2020) 136 (Supplement 1): 30.

https://doi.org/10.1182/blood-2020-140347

Published: 2020

Journal Articles

Analysis of Clinical Characteristics and Survival of Multiple Myeloma Patients with Fractures

Luis Carlos Gómez Mier, MD, Vanessa Salinas Alvarez, Alejandro Ras El Abiad, Camilo Soto Montoya, Humberto Martínez Cordero, MD

Blood (2020) 136 (Supplement 1): 17.

https://doi.org/10.1182/blood-2020-138570

Published: 2020

Journal Articles

Sars Cov-2/COVID-19 in Multiple Myeloma Latin-American Patients COVID-Lamm Study on Behalf of Gelamm ( Grupo de Estudio Latino- Americano de Mieloma Múltiple )

Blood (2020) 136 (Supplement 1): 24–26.

https://doi.org/10.1182/blood-2020-142823

Published: 2020

Journal Articles

Acute Promyelocytic Leukemia (APL): Seasonal Behavior in Colombia for the Period 2009-2019

Humberto Martínez Cordero, MD, Juan Ospina Idarraga, Xiomara Castañeda Contreras, Alejandro Rico Mendoza, Henry Idrobo, MD, Lina Martinez Correa, Jenifer Buitrago, Alexandra Porras Ramírez

Blood (2020) 136 (Supplement 1): 38–39.

https://doi.org/10.1182/blood-2020-143191

Published: 2020

NARROW

Unknown Risk Should be Considered High-Risk in Myelodysplastic Neoplasms: A Multicenter Study in 219 Patients in Colombia

Using Polatuzumab Plus Chemotherapy for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Real-World Study from the Grupo De Estudio De Linfoproliferativos De Latinoamerica (GELL)

Low/Intermediate Doses of Melphalan in the Treatment of Triple-Exposed/Refractory Multiple Myeloma: A Case Series from a Reference Center for the Treatment of Multiple Myeloma in Colombia

Primary CNS Lymphoma in Latin America: A Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL) Survey in 80 Cancer Centers in Latin America

Clinical Features and Prognostic Factors in Multiple Myeloma Patients from Colombia. Real-World Data from Renehoc Registry

Renal Failure in Patients with Newly Diagnosed Multiple Myeloma Eligible for Autologous Stem Cell Transplant in LATAM - on Behalf of Gelamm

Freedo mm : A Multicenter Observational Study of Multiple Myeloma in Second Relapse in Colombia

Complete Response As a Determinant of Survival in Plasmablastic Lymphoma Plasmablat- GELL001 Study

Multiple Myeloma Patients Aged 40 Years and Younger Have the Same Prognosis As Older Patients in an Analysis of Real-World Evidence from Latin America: A Study of 1,316 Patients from the Gelamm Latin American Multiple Myeloma Studygroup

Treatment Patterns and Survival of Patients with Relapsed and Refractory Classical Hodgkin Lymphoma in Latin America

Outcomes after First Rescue Treatment in Patients with Relapsed or Refractory Multiple Myeloma in Colombia

Clinico-Epidemiological Features of Elderly Patients with Peripheral T-Cell Lymphoma Not Otherwise Specified: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

A Novel Prognostic Index for Patients with EBV-DLBCL NOS: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Clinicopathological Features and Outcomes of EBV Positive and Negative DLBCL: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Biological and Classical Prognostic Factors with Impact on Overall Survival in Patients with Early Stage (I/II) Diffuse Large B-Cell Lymphoma: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Multiple Myeloma Mortality Incidence Prevalence of Disease - Mmy Mind Study

Plasmablastic Lymphoma : 12 Year Experience from a Single Center in Colombia -South America

Analysis of Clinical Characteristics and Survival of Multiple Myeloma Patients with Fractures

Sars Cov-2/COVID-19 in Multiple Myeloma Latin-American Patients COVID-Lamm Study on Behalf of Gelamm ( Grupo de Estudio Latino- Americano de Mieloma Múltiple )

Acute Promyelocytic Leukemia (APL): Seasonal Behavior in Colombia for the Period 2009-2019

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only